Patent Assignment
Reel/Frame 061884/0407
Change of Name
Recorded: 2022-11-04
Pages: 2
Assignor
CELL THERAPEUTICS, INC.
Executed: 2014-06-04
Assignee
CTI BIOPHARMA CORP.
3101 WESTERN AVE., SUITE 800, SEATTLE, WASHINGTON, 98121
Covered Property
(1)
Oxygen Linked Pyrimidine Derivatives
Application:
17/902,539 →
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 4, 2022
From: BLANCHARD, STEPHANIE; LEE, CHENG HSIA ANGELINE; NAGARAJ, HARISH KUMAR MYSORE; SUN, ERIC T.
To: S*BIO PTE LTD.
Reel/Frame 061661/0700 →
Assignment of Assignor's Interest
Nov 4, 2022
From: S*BIO PTE LTD.
To: CELL THERAPEUTICS, INC.
Reel/Frame 061661/0708 →
Merger
Oct 3, 2024
From: CTI BIOPHARMA CORP.
To: SOBI, INC.
Reel/Frame 068782/0512 →